Ranjan Banerjee
Critic · DISC type CRanjan Banerjee is the Senior Director of CMC at Axsome Therapeutics, leading drug substance chemical development, manufacturing, and regulatory CMC. His extensive career includes pivotal roles at Merck and Constellation Pharmaceuticals. He earned his Ph. D. from Wake Forest University and is a published researcher in chemistry.
His professional drive is deeply personal, inspired by his fathers battles with Parkinsons and depression. Ranjan has expressed immense pride in developing treatments for conditions that have personally affected his family, including his own experience with migraines, making his work particularly meaningful.
Two drugs he helped get FDA-approved, Auvelity (depression) and Symbravo (migraine), address conditions his family has faced.
Read the full overview →How Ranjan shows up
They don’t appreciate bells and whistles unless backed by data. They choose to analyze logically and value facts to emotions. They are quite likely to negotiate on pricing or other key terms.
Topics Ranjan cares about
Work history
Media appearances
DISC profile (public)
Calculativeness (C)
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
Other Axsome Therapeutics, Inc. Employees
Explore more public profiles from related professionals.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.